American Journal of Clinical Oncology-Cancer Clinical Trials

Papers
(The H4-Index of American Journal of Clinical Oncology-Cancer Clinical Trials is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
PARP Inhibitors in Newly Diagnosed and Recurrent Ovarian Cancer40
Impact of Sarcopenia, BMI, and Inflammatory Biomarkers on Survival in Advanced Hepatocellular Carcinoma Treated With Anti-PD-1 Antibody40
Treatment and Prevention of Brain Metastases in Small Cell Lung Cancer30
The Impact of COVID-19 on Patients With Cancer28
Early Palliative Care Is Associated With Reduced Emergency Department Utilization in Pancreatic Cancer24
Breast and Cervical Cancer Screening Disparities in Transgender People21
Impact of Use of Antibiotics on Response to Immune Checkpoint Inhibitors and Tumor Microenvironment20
Trends in Diagnosis and Treatment of Metastatic Cancer in the United States19
Vaccination and Immune Checkpoint Inhibitors19
Multiple Site SBRT in Pediatric, Adolescent, and Young Adult Patients With Recurrent and/or Metastatic Sarcoma13
Outcomes of Stereotactic Radiosurgery and Immunotherapy in Renal Cell Carcinoma Patients With Brain Metastases13
Social Determinants of Health in Oncology13
Proton Pump Inhibitors and Cancer Risk12
0.050381898880005